Cited by 878Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., Lee, T.·1975·Science

DOI 10.1126/science.1145194

Open this paper in CoChat — free account

Abstract

Neuroleptic (antipsychotic) drugs inhibited the electrically stimulated release of [3 H]dopamine from rat striatal slices. The concentrations for 50 percent inhibition (ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia. The correlation includes butyrophenones, phenothiazines, reserpine, pimozide, clozapine, and (+)-butaclamol. Clinically inactive isomers [trans-thiothixene,trans-flupenthixol, and (-)-butaclamol] required 20 to 1000 times higher concentrations than the active isomers to inhibit release. Compared to the inhibition of [3 H]dopamine release, much higher neuroleptic concentrations were needed to inhibit the electrically stimulated release of other neurotransmitters—[3 H]acetylcholine, [3 H]GABA (γ-aminobutyric acid). The neuroleptic drugs may block the presynaptic coupling between impulse and neurosecretion.

Integrity signals

Registry

Crossref · 10.1126/science.1145194

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. M. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,241
Self-citation
Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,156
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
Bunney, B. S., Walters, J. R., Roth, R. H., & Aghajanian, G. K. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N., Butcher, S. G., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Drugs, Neurotransmitters, and Schizophrenia
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. A. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
Jm, V. R. (1966) · PubMed · Cited by 508
Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs
Clement‐Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb09104.x · Cited by 417
IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.
Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1965) · PubMed · Cited by 348
Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
Matthysse, S. (1973) · PubMed · Cited by 338

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 9

Aghajanian, G. K., Frontiers in Neurology and Neuroscience Research: 4 (1974).
FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 19 (1971).
FARNEBO, L. O., ACTA PHYSIOLOGICA SCANDINAVICA 371: 35 (1971).
Munkvad, I., The Neuroleptics. Modern Problems in Pharmacopsychiatrv 5: 44 (1970).
RITCHIE, J.M., ON ACTIVE STRUCTURE OF LOCAL ANESTHETICS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 133: 241 (1961).
SEEMAN, P, FEDERATION PROCEEDINGS 33: 246 (1974).
SOTELO, C, ULTRASTRUCTURAL IDENTIFICATION OF NIGRAL DOPAMINERGIC CELLS IN RAT, JOURNAL DE PHARMACOLOGIE 5: 55 (1974).
STAWARZ, R.J., SIGNIFICANCE OF INCREASE OF HOMOVANILLIC-ACID (HVA) CAUSED BY ANTIPSYCHOTICS IN CORPUS STRIATUM AND LIMBIC FOREBRAIN, FEDERATION PROCEEDINGS 33: 246 (1974).
ZIVKOVIC, B, SPECIFIC ACTIVATION OF STRIATAL TYROSINE-HYDROXYLASE (TH) BY NEUROLEPTICS, FEDERATION PROCEEDINGS 33: 536 (1974).

Sorted by citations

Items 501–600 of 878

The D2R-DISC1 protein complex and associated proteins are altered in schizophrenia and normalized with antipsychotic treatment
Wang, J.-J., Su, P., Yang, J., Xu, L.-H., Yuan, A.-H., Li, C.-B., Zhang, T.-H., Dong, F., Zhou, J.-J., Samsom, J. N., et al. (2022) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.210145 · Cited by 12
Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse
Feldcamp, L. A., Boutros, P. C., Raymond, R., Fletcher, P. J., Nóbrega, J. N., & Wong, A. H. C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.85 · Cited by 15
Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice
Adem, A., Madjid, N., Stiedl, O., Bonito-Oliva, A., Konradsson‐Geuken, Å., Holst, S., Fisone, G., & Ögren, S. O. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.007 · Cited by 14
Disconnectivity between the raphe nucleus and subcortical dopamine-related regions contributes altered salience network in schizophrenia
Han, S., Cui, Q., Guo, X., Fan, Y., Guo, J., Zong, X., Hu, M., Lu, F., Chen, X., & Chen, H. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.006 · Cited by 14
Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia
Matsuzaki, S., & Tohyama, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1097 · Cited by 13
“Based on accumulating studies of the symptoms of schizophrenia, several hypotheses based on abnormal neurotransmission are supported, such as the dopamine hypothesis, which is based on hyperactive dopaminergic signal transduction, the glutamate hypothesis, which is based on hypofunction of glutamatergic signaling, and…”
Background
The Science of Antipsychotics: Mechanistic Insight
Tamminga, C. A. (2003) · CNS Spectrums · doi:10.1017/s1092852900008129 · Cited by 14
THE UPTAKE AND RELEASE OF [3H]‐2‐AMINO‐6,7‐DIHYDROXY1,2,3,4‐TETRAHYDRONAPHTHALENE (ADTN) BY STRIATAL NERVE TERMINALS
DAVIS, A., Roberts‎, P., & Woodruff, G. N. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07788.x · Cited by 14
Schizophrenia and neurosurgery: systematic review and theories
Dutta, R. R., Picton, B., Brown, N. J., Yang, C. C., Lee, M. Y., Sung, H., Lopez, A. M., & Paff, M. R. (2023) · Neurosurgical FOCUS · doi:10.3171/2022.11.focus22620 · Cited by 13
Synthesis and evaluation of ligands for D2-like receptors: The role of common pharmacophoric groups
Sikazwe, D., Nkansah, N., Altundaş, R., Zhu, X. Y., Roth, B. L., Setola, V., & Ablordeppey, S. Y. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.054 · Cited by 13
Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials
Rao, N. P., & Remington, G. J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.795945 · Cited by 13
“dopamine hypothesis posited schizophrenia to be a disorder of general dopaminergic hyperactivity [4,5] based on two lines of investigation: i) several landmark studies reported dopamine neurotransmission as the target of antipsychotic action [6-9]; and ii) amphetamine, cocaine, and methylphenidate, which enhance synap…”
Background
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
Kantrowitz, J. T. (2021) · CNS Drugs · doi:10.1007/s40263-021-00864-3 · Cited by 13
Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
Zhang, Y., Peng, Y., Song, Y., Zhou, Y., Zhang, S., Yang, G., Yang, Y., Li, W., Yue, W., Lv, L., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2535 · Cited by 13
“The func- tional connectivity (FC) of the striatum is substantially influenced by dopaminergic transmission (Seeman & Lee, 1975).”
Background
The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands
Salmas, R. E., Stein, M., Yurtsever, M., Seeman, P. M., Erol, İ., Mestanoğlu, M., & Durdağı, S. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1206487 · Cited by 13
“It is obvious that all marketed antipsychotics produce their effect through the antagonizing of D2R has proved that enhanced D2R signaling is a major part of the pathophysiology of schizophrenia (Seeman, 2006; Seeman & Lee, 1975).”
BackgroundSelf-citation
Characterization of [I]S(−)5- binding to dopamine D2-like receptors expressed in cell lines
Vessotskie, J. M., Kung, M., Chumpradit, S., & Kung, H. F. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00076-2 · Cited by 13
Haloperidol, spiperone, pimozide and aripiprazole reduce intracellular dopamine content in PC12 cells and rat mesencephalic cultures: Implication of inhibition of vesicular transport
Matsuo, T., Izumi, Y., Wakita, S., Kume, T., Takada‐Takatori, Y., Sawada, H., & Akaike, A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.043 · Cited by 13
“These antipsychotics also inhibited the electrically-stimulated dopamine release from rat striatal slices (Seeman and Lee, 1975; Dismukes and Mulder, 1977) and it was suggested that the effect of haloperidol was not related to the interaction with dopamine D2 receptors (Dismukes and Mulder, 1977).”
Background
Biochemical pharmacology of Gilles de la Tourette's syndrome
Messiha, F. S. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80062-9 · Cited by 13
Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum
Yamada, S., Yokoo, H., & Nishi, S. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90720-3 · Cited by 13
Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy
Lopes, R. D. M., de Souza, A. C. S., Otręba, M., Rzepecka‐Stojko, A., Tersariol, I. L. S., & Rodrigues, T. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116075 · Cited by 13
Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms?
Thomas, M., Szentgyorgyi, T., Vanes, L. D., Mouchlianitis, E. D., Barry, E. F., Patel, K., Wong, K., Joyce, D. W., & Shergill, S. S. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113607 · Cited by 13
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
Shin, S. H., Jung, W. H., McCutcheon, R. A., Veronese, M., Beck, K., Lee, J., Lee, Y., Howes, O. D., Kim, E., & Kwon, J. S. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0033 · Cited by 12
Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories
Zhou, C., Nutt, D., & Davies, S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221115758 · Cited by 12
“Almost all of the drugs which entered clinical use for psychotic disorders in this era were strong or moderate dopamine D2 receptor antagonists, and a seminal paper (Seeman and Lee, 1975) illustrated that their potency was linked to affinity for this receptor.”
Background
Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61
Xu, J., Kurup, P. K., Nairn, A. C., & Lombroso, P. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0555-x · Cited by 12
Stem Cells for Improving the Treatment of Neurodevelopmental Disorders
Donegan, J. J., & Lodge, D. J. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0265 · Cited by 13
Conformationally Constrained Butyrophenones with Affinity for Dopamine (D1, D2, D4) and Serotonin (5-HT2A, 5-HT2B, 5-HT2C) Receptors: Synthesis of Aminomethylbenzo[b]furanones and Their Evaluation as Antipsychotics
Raviña, E., Casariego, I., Masaguer, C. F., Fontenla, J. A., Montenegro, G. Y., Rivas, M. E., Loza, M. I., Enguix, M. J., Villazón, M., Cadavid, M. I., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0009890 · Cited by 12
Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia
Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 12
[18F]Haloperidol binding in baboon brain in vivo
Yousef, K. A., Fowler, J. S., Volkow, N. D., Dewey, S. L., Shea, C. E., Schlyer, D. J., Gatley, S. J., Logan, J., & Wolf, A. P. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(95)02014-4 · Cited by 12
Inhibition of Trifluoperazine-induced DNA Fragmentation by Cyclic AMP Mediated Signaling
Kang, U. G., Kim, M. J., Suh, P., Ryu, S. H., Park, J.-B., Kim, J.-H., Kim, Y. S., & Lee, Y. H. (1999) · Molecules and Cells · doi:10.1016/s1016-8478(23)13590-4 · Cited by 12
Comparative effects of short- and long-term treatment with neuroleptics on behavioural activity as well as dopamine turnover in striatum
Rastogi, R. B., Singhal, R. L., & Lapierre, Y. D. (1982) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(82)90007-6 · Cited by 12
Haloperidol versus first generation antipsychotics for schizophrenia
Dold, M., Li, C., Tardy, M., & Leucht, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009831 · Cited by 12
Striosomes Target Nigral Dopamine-Containing Neurons via Direct-D1 and Indirect-D2 Pathways Paralleling Classic Direct-Indirect Basal Ganglia SystemsPreprint
Lazaridis, I., Crittenden, J. R., Ahn, G., Hirokane, K., Yoshida, T., Wickersham, I. R., Mahar, A., Skara, V., Loftus, J. H., Parvataneni, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.01.596922 · Cited by 12
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Kiss, B., Krámos, B., & Laszlovszky, I. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.785592 · Cited by 11
Impact of Gestational Haloperidol Exposure on miR-137-3p and Nr3c1 mRNA Expression in Hippocampus of Offspring Mice
Yoshino, Y., Kumon, H., Shimokawa, T., Yano, H., Ochi, S., Funahashi, Y., Iga, J., Matsuda, S., Tanaka, J., & Ueno, S. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac044 · Cited by 11
“Numerous studies have investigated the pathogenesis of SCZ based on several hypotheses, including dopamine (Seeman and Lee, 1975) and glutamate hypotheses (Javitt and Zukin, 1991).”
Background
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
Jauhar, S., McCutcheon, R. A., Veronese, M., Borgan, F., Nour, M. M., Rogdaki, M., Pepper, F., Stone, J. M., Egerton, A., Vamvakas, G., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02479-2 · Cited by 11
Dopamine Receptors and the Treatment of Schizophrenia
Ginovart, N., & Kapur, S. (2009) · The Receptors · doi:10.1007/978-1-60327-333-6_16 · Cited by 11
Ultrastructural Distinctions Between Treatment Responders and Non-Responders in Schizophrenia: Postmortem Studies of the Striatum
Roberts, R., Roche, J. K., Somerville, S., & Conley, R. (2012) · InTech eBooks · doi:10.5772/31396 · Cited by 12
No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol
Bolstad, I., Andreassen, O. A., Groote, I. R., Haatveit, B. C., Server, A., & Jensen, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00296 · Cited by 11
“The antipsychotic effect of antipsychotic drugs is suggested to be directly related to dopamine D2 receptor affinity (Seeman and Lee, 1975).”
Background
Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity
Hsu, K.-C., & Wang, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179575 · Cited by 11
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11
Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase
Costa, E., Gnegy, M. E., & Uzunov, P. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00587774 · Cited by 11
Biochemical Effects of Neuroleptic Drugs
Bartholini, G., & Lloyd, K. G. (1980) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-67538-6_9 · Cited by 11
Setting the beat of an internal clock: Effects of dexamphetamine on different interval ranges of temporal processing in healthy volunteers
Graham‐Schmidt, K. T., Martin‐Iverson, M. T., & Waters, F. A. V. (2019) · PsyCh Journal · doi:10.1002/pchj.274 · Cited by 11
Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors
Mach, R. H. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.05.002 · Cited by 10
The Altered Supramolecular Structure of Dopamine D2 Receptors in Disc1-deficient Mice
Onishi, T., Sakamoto, H., Namiki, S., & Hirose, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20090-0 · Cited by 10
Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia
Nakata, S., Yoshino, Y., Okita, M., Kawabe, K., Yamazaki, K., Ozaki, Y., Mori, Y., Ochi, S., Iga, J., & Ueno, S. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.135 · Cited by 9
“Several hypotheses about the pathogenesis of SCZ, such as the dopamine hypothesis (Seeman & Lee, 1975) and the glutamate hypothesis (Hu et al., 2015), have been well discussed.”
Background
What is the evidence for antipsychotic medication and alternative psychosocial interventions for people with acute, non-affective psychosis?
Jauhar, S., & Lawrie, S. M. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00293-5 · Cited by 10
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia
Tardy, M., Dold, M., Engel, R. R., & Leucht, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009227.pub2 · Cited by 10
Dexamphetamine effects on prepulse inhibition (PPI) and startle in healthy volunteers
Chitty, K., Albrecht, M., Graham, K. T., Kerr, C., Lee, J. W. Y., Iyyalol, R., & Martin-Iverson, M. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3395-z · Cited by 12
“Firstly, all effective antipsychotics reduce activity at dopamine D2 receptors (Seeman et al. 1975; Seeman and Lee 1975; Creese et al. 1976).”
Background
Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis
Inta, D., Lima‐Ojeda, J. M., Gass, P., & Fusar‐Poli, P. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803251998 · Cited by 10
“In the seventies such a theory was further corroborated by reports showing that antipsychotic efficacy was directly linked to their ability to block the dopamine D2 receptor [23,24].”
Background
Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex
Li, Y.-C., Yang, S.-S., & Gao, W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.002 · Cited by 10
“Indeed, all antipsychotic drugs exert their actions by blocking D2Rs (Creese et al., 1976; Seeman and Lee, 1975; Seeman et al., 1976).”
BackgroundMethod
Molecular and cellular aspects of neurotransmission and neuromodulation.
Martínez-Rodríguez, R., & Martínez‐Murillo, R. (1994) · PubMed · Cited by 10
Molecular and Cellular Ace:infects of Neurotransmission and IMeuromodulation
Martínez-Rodríguez, R., & Martínez‐Murillo, R. (1994) · International review of cytology · doi:10.1016/s0074-7696(08)62089-6 · Cited by 10
Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol
Yamada, S., Yokoo, H., Harajiri, S., & Nishi, S. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90080-a · Cited by 10
Thiethylperazine
Rotrosen, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770330086008 · Cited by 10
Perceptual Dyscontrol--A Possible Organizing Principle for Schizophrenia Research*
Corbett, L. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.2.249 · Cited by 10
“…is evidence of abnormal adenosine triphosphatases in schizophrenia (e.g., Cho and Meltzer 1974); antipsychotic drugs act presynaptically both neurophysiologically and biochemically (Quastel, Hackett, and Okamoto 1972, Corbett et al. 1974, and Seeman and Lee 1975) and also at postsynaptic sites.”
Background
Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies
Lamelle, M., & Abi‐Dargham, A. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.4/mlamelle · Cited by 10
Effects of haloperidol and apomorphine on catecholamine metabolism in brain slices
Delanoy, R. L., & Dunn, A. J. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90564-0 · Cited by 10
Similarities and contrasts between the effects of amphetamine and apomorphine in rats chronically treated with haloperidol
Gianutsos, G., Hynes, M. D., Drawbaugh, R. B., & Lal, H. (1978) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(78)90062-0 · Cited by 10
Alcoholism and Schizophrenia: Diagnostic and Therapeutic Considerations
Ban, T. A. (1977) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1977.tb05855.x · Cited by 10
Quantitative correlation of dopamine-dependent adenylate cyclase with responses to levodopa in various mice.
Tang, L., & Cotzias, G. C. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.1242 · Cited by 10
The effect of neuroleptics on the dopaminergic and cholinergic systems in sympathetic ganglia.
Nakamura, J. (1978) · The Kurume Medical Journal · doi:10.2739/kurumemedj.25.241 · Cited by 10
Barbiturate Physical Dependence in Mice: Effects of Neuroleptics and Diazepam on the Withdrawal Syndrome
Belknap, J. K. (1978) · Clinical Toxicology · doi:10.3109/15563657809150013 · Cited by 10
Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia
Tardy, M., Leucht, S., Potapov, A., Engel, R. R., Dold, M., & Kissling, W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009227 · Cited by 10
NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia
Dwyer, G. E., Johnsen, E., & Hugdahl, K. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.025 · Cited by 9
“…are alternately known (L ´ opez-Mu ˜ noz et al., 2005), was strongly correlated with their ability to block D2 type dopamine receptors (Creese et al., 1976; Seeman and Lee, 1975; Seeman et al., 1976) but that no such correlation was observed with D1, D3, or D4 receptors (Seeman, 1980, 1987, 2006).”
The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction
Liddle, P. F., & Sami, M. B. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.007 · Cited by 9
“The role of dopamine in schizophrenia has been a focus of research since Seeman and Lee (71) demonstrated that the ef ﬁ cacy of antipsychotics was strongly correlated with af ﬁ nity for the dopamine D 2 receptor.”
Background
Schizophrenia Aetiology and Drug Therapy: A Tale of Progressive Demystification and Strides in Management
Onaolapo, A. Y., & Onaolapo, O. J. (2018) · Advances in Pharmacology and Pharmacy · doi:10.13189/app.2018.060201 · Cited by 9
The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain
Shapiro, L. A., Offord, S. J., & Ordway, G. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00155-j · Cited by 9
Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life
Velley, L., Blanc, G., Tassin, J., Thierry, A. M., & Glowinski, J. (1975) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501817 · Cited by 9
[125I](S)-trans-7-OH-PIPAT: A potential spect imaging agent for sigma binding sites
Garner, S. E., Kung, M., Foulon, C. F., Chumpradit, S., & Kung, H. F. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00865-5 · Cited by 9
Modulation of (–)-sulpiride-induced increase in electrically-evoked release of dopamine from rat striatal slices
Yamada, S., Yokoo, H., & Nishi, S. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05580.x · Cited by 9
Suitability of amfonelic acid-induced locomotor stimulation in mice as a model for the evaluation of classical and atypical antipsychotics
Menon, M. K. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90029-7 · Cited by 9
Dopaminergic stimulants and cyclic nucleotides in mouse brain
Gumułka, S. W., Dinnendahl, V., Sch�nh�fer, P. S., & Stock, K. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00509767 · Cited by 9
“Inhibition of dopamine release has also been shown for a variety of antipsychotic drugs by measuring the release of labeled dopamine from rat striatal slices following electrical stimulation (Seeman and Lee, 1975).”
Background
Interactions Between Acetylcholine and Dopamine in the Basal Ganglia
Tarsy, D. (1979) · Springer eBooks · doi:10.1007/978-1-4613-2934-3_23 · Cited by 9
Presynaptic Actions and Dopamine in the Neostriatum
Arbuthnott, G. W., Brown, J. R., Kapoor, V., & Whale, D. (1984) · Advances in behavioral biology · doi:10.1007/978-1-4684-1212-3_9 · Cited by 9
Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report
Crowley, T. J., Rutledge, C. O., Hoehn, M. M. M., Stallings, M. A., & Sundell, S. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.6.703 · Cited by 9
Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia
Tardy, M., Leucht, S., Potapov, A., Engel, R. R., Huhn, M., & Kissling, W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009369 · Cited by 9
Neurophysiological Properties of Neuroleptic Agents in Animals
Jurna, I. (1980) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-67538-6_7 · Cited by 9
GABAA-Rezeptorfunktion im Fokus
Nikolaus, S., Hautzel, H., & Müller, H. W. (2014) · Nuklearmedizin - NuclearMedicine · Cited by 8
The dopamine D1 receptor positive allosteric modulator, DETQ, improves cognition and social interaction in aged mice and enhances cortical and hippocampal acetylcholine efflux
Rajagopal, L., Huang, M., Mahjour, S., Ryan, C., Elzokaky, A., Svensson, K. A., & Meltzer, H. Y. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114766 · Cited by 8
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor
Shamy, M. C. F., Zai, C. C. H., Basile, V. S., Kennedy, J. L., Müller, D. J., & Masellis, M. (2011) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/187569211795508448 · Cited by 8
Who pioneered the use of antipsychotics in North America?
Stip, É. (2015) · Europe PMC (PubMed Central) · Cited by 8
Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia
Zakharyan, R., Ghazaryan, H., Kocourková, L., Chavushyan, A., Mkrtchyan, A. G., Žižková, V., Arakelyan, A., & Petřek, M. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.12.011 · Cited by 8
Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application
Seiler, W., Wetzel, H., Hillert, A., Schöllnhammer, G., Langer, M. R., Barlage, U., & Hiemke, C. (1994) · Psychopharmacology · doi:10.1007/bf02247478 · Cited by 8
Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients
Aslostovar, L., Boyd, A. L., Benoit, Y. D., Lu, J. D., García‐Rodríguez, J. L., Nakanishi, M., Porras, D. P., Reid, J. C., Mitchell, R. R., Leber, B. F., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100202 · Cited by 8
Long-term treatment with clozapine on aging mice
Rolsten, C., Claghorn, J. L., & Samorajski, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90544-7 · Cited by 8
The prolactin-stimulating potency of reserpine in man
Asnis, G. M., Sachar, E. J., Halbreich, U. M., Ostrow, L. C., Nathan, R. S., & Halpern, F. S. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90059-7 · Cited by 8
The Impact of Biochemistry on the Problem of Schizophrenia
Richter, D. (1976) · Elsevier eBooks · doi:10.1016/b978-0-08-020928-9.50012-8 · Cited by 8
Chronic fluphenazine treatment modifies circadian rhythms of neurotransmitter receptor binding in rat brain
Naber, D., Wirz‐Justice, A., & Kafka, M. S. (1982) · Journal of Neural Transmission · doi:10.1007/bf01243449 · Cited by 8
Propranolol and schizophrenia: Objective evidence of efficacy
Gruzelier, J. H., & Yorkston, N. J. (1978) · Springer eBooks · doi:10.1007/978-94-011-6206-7_13 · Cited by 8
EVIDENCE FOR AN INHIBITORY PRESYNAPTIC COMPONENT OF NEUROLEPTIC DRUG ACTION
de Belleroche, J., & Bradford, H. F. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb10993.x · Cited by 8
Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.
Tang, L., & Cotzias, G. C. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.769 · Cited by 8
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia
Tardy, M., Leucht, S., Potapov, A., Kissling, W., Engel, R. R., Huhn, M., & Komossa, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009268 · Cited by 8
Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications
Miedlich, S. U., & Lamberti, J. S. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15301 · Cited by 9
“13,14 Researchduringthe1970ssubsequentlyshowed that amphetamines, which increase brain dopamine levels by inhibiting dopamine reuptake, can cause psychosis in individuals without schizophrenia.”
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease
Perez, S. M., Boley, A. M., McCoy, A. M., & Lodge, D. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087196 · Cited by 6
GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
Lee, N., Zheng, G., Leggas, M. L., Janganati, V., Nickell, J. R., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258699 · Cited by 7
“Since MUD is often associated with decreased body weight (Sommers et al., 2006), increases in food intake may be a beneficial side effect.”
Background
Sex/Gender differences in schizophrenia: Thinking back and thinking forward
Seeman, M. V. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114738 · Cited by 7
Design, synthesis, and SAR of N-((1-(4-(propylsulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide inhibitors of glycine transporter-1
Cioffi, C. L., Wolf, M. A., Guzzo, P. R., Sadalapure, K., Parthasarathy, V., Dethe, D. H., Maeng, J.-H., Carulli, E., Loong, D. T. J., Fang, X., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.006 · Cited by 7
Rational design, synthesis and evaluation of (6aR∗,11bS∗)-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2′,1′:6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent
Chakrabarty, R., Rao, J., Anand, A., Roy, A. D., Roy, R., Shankar, G., Dua, P., & Saxena, A. K. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.018 · Cited by 7
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials
Rao, N. P., & Remington, G. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.873790 · Cited by 8
“The initial model hypothesised general hyperactivity of the dopaminergic system, predominantly based on pharmacological studies indicating dopamine neurotransmission as the target of antipsychotic action [9-12].”
Background
Applications of Clinical Dopamine Imaging
Lindsey, K. P., & Gatley, S. J. (2006) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2006.06.003 · Cited by 7
Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats.
Rakovska, A., Javitt, D., Petkova-Kirova, P., Balla, A., Ang, R. L., & Kalfin, R. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.005 · Cited by 4

Authors: Seeman, P., & Lee, T.
Affiliations: University of Toronto (CA)
ORCID: Seeman, P.
Lee, T.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1975-06-20
Volume: 188
Issue: 4194
Pages: 1217-1219
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1145194
OpenAlex: W2006122360
Cited by: 869
References: 35
Citations by year: 2026: 5 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 13 · 2020: 18 · 2019: 36 · 2018: 21 · 2017: 30 · 2016: 26 · 2015: 28 · 2014: 37 · 2013: 23 · 2012: 32
FWCI: 62.55
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: antipsychotic drugs, presynaptic dopamine release, striatum, spiperone, thioridazine, butyrophenones, phenothiazines, reserpine, pimozide, clozapine, butaclamol, stereoisomers, acetylcholine release, GABA release, schizophrenia
MeSH terms: Acetylcholine, Animals, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Electric Stimulation, gamma-Aminobutyric Acid, Haloperidol, Humans, Male, Neurons, Neurosecretion, Schizophrenia, Tranquilizing Agents, Tritium, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks